European mass spectrometer vendors are transforming their offerings from basic laboratory equipment into effective diagnostic equipment. The European Union’s expanded In Vitro Diagnostic Regulation (IVDR) for medical devices, set to take effect in May 2022, will have a dramatic effect on the industry.
Manufacturers’ next-generation mass spectrometers are smart and predictive, allowing for continuous system monitoring, automated diagnostics, and integrated troubleshooting routines. Users can monitor the state of the system from anywhere in the laboratory network and perform diagnostics.
Demand is primarily in the areas of research and routine analysis in food safety, environmental monitoring related to the shift to renewable energy, and healthcare to prevent disease and lower death rates.
The report projects that equipment manufacturers that provide customers with complete solutions (equipment, reagents, and consumables) are most likely to be successful in the long term.
The report reveals the market positioning of companies in an industry using their Growth and Innovation scores as highlighted in the reports methodology. The document presents competitive profiles on each of the companies in the report based on their strengths, opportunities, and a small discussion on their positioning. The report analyzes hundreds of companies in the industry and benchmarks them across 10 criteria on the report radar, where the leading companies in the industry are then positioned. Industry leaders on both the Growth and Innovation indices are recognized as best practice recipients.